Who is sponsoring NCT02210403?

NCT02210403 is sponsored by Universitaire Ziekenhuizen KU Leuven.

What drugs are being tested in NCT02210403?

Interventions in NCT02210403: transcranial direct current stimulation (tDCS).

What condition does NCT02210403 study?

NCT02210403 studies Transcranial Direct Current Stimulation, Cerebrovascular Accident (CVA).

Is NCT02210403 still recruiting?

NCT02210403 is currently completed. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT02210403

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of tDCS on the Arm and Hand Function in Stroke Patients

Completed NA Last updated 28 March 2023

What this trial tests

NA trial testing transcranial direct current stimulation (tDCS) in Transcranial Direct Current Stimulation in 26 participants. Completed in 28 September 2014.

Timeline

18 April 2013

Primary endpoint
28 September 2014

28 September 2014

Quick facts

Lead sponsor	Universitaire Ziekenhuizen KU Leuven
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	26
Start date	18 April 2013
Primary completion	28 September 2014
Estimated completion	28 September 2014
Sites	1 location across Belgium

Drugs / interventions tested

transcranial direct current stimulation (tDCS)

Conditions studied

Transcranial Direct Current Stimulation — all drugs for Transcranial Direct Current Stimulation →
Cerebrovascular Accident (CVA) — all drugs for Cerebrovascular Accident (CVA) →

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

18 and older, any sex, with Transcranial Direct Current Stimulation or Cerebrovascular Accident (CVA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether tDCS in combination with motor training can improve hand and arm function in stroke patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke.
Elsner B, Kugler J, Pohl M, Mehrholz J. · · 2016 · cited 89× · PMID 26996760 · DOI 10.1002/14651858.cd009645.pub3
Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke.
Elsner B, Kugler J, Pohl M, Mehrholz J. · · 2020 · cited 80× · PMID 33175411 · DOI 10.1002/14651858.cd009645.pub4

Verify or expand the search:

Other trials of transcranial direct current stimulation (tDCS)

Trials testing the same drug.

NCT07535788 — Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting · not yet recruiting
NCT07458503 — tDCS Combined With Constraint-Induced Therapy in Post-Stroke Upper Limb Rehabilitation · NA · not yet recruiting
NCT07500064 — Transcranial Direct Current Stimulation for Depression · NA · not yet recruiting
NCT07228468 — Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME) · NA · recruiting
NCT06883266 — Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD · NA · recruiting

Other recruiting trials for Transcranial Direct Current Stimulation

Currently open trials in the same condition.

NCT06517706 — Brain Research and Integrative Neuroscience Network for COVID-19 · NA · recruiting
NCT06556043 — Investigating the Effects of Transcranial Direct Current Stimulation to Different Brain Regions on Ankle Tracking Motor · NA · recruiting
NCT06505460 — Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's · NA · recruiting
NCT06241963 — High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy · NA · recruiting
NCT06121635 — The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis · NA · active not recruiting

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02210403 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02210403.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing